Literature DB >> 11016927

Non-redundant signal transduction of interleukin-6-type cytokines. The adapter protein Shc is specifically recruited to rhe oncostatin M receptor.

H M Hermanns1, S Radtke, F Schaper, P C Heinrich, I Behrmann.   

Abstract

The common use of the cytokine receptor gp130 has served as an explanation for the extremely redundant biological activities exerted by interleukin (IL)-6-type cytokines. Indeed, hardly any differences in signal transduction initiated by these cytokines are known. In the present study, we demonstrate that oncostatin M (OSM), but not IL-6 or leukemia inhibitory factor, induces tyrosine phosphorylation of the Shc isoforms p52 and p66 and their association with Grb2. Concomitantly, OSM turns out to be a stronger activator of ERK1/2 MAPKs. Shc is recruited to the OSM receptor (OSMR), but not to gp130. Binding involves Tyr(861) of the OSMR, located within a consensus binding sequence for the Shc PTB domain. Moreover, Tyr(861) is essential for activation of ERK1/2 and for full activation of the alpha(2)-macroglobulin promoter, but not for an exclusively STAT-responsive promoter. This study therefore provides evidence for qualitative differential signaling mechanisms exerted by IL-6-type cytokines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016927     DOI: 10.1074/jbc.M005408200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

2.  Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.

Authors:  Ana P Costa-Pereira; Nair A Bonito; Michael J Seckl
Journal:  Am J Cancer Res       Date:  2011-06-22       Impact factor: 6.166

3.  STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.

Authors:  Benjamin L Bryson; Damian J Junk; Rocky Cipriano; Mark W Jackson
Journal:  Cell Cycle       Date:  2016-11-28       Impact factor: 4.534

Review 4.  Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor.

Authors:  Hiroyuki Hirai; Peter Karian; Nobuaki Kikyo
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

Review 5.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Authors:  Peter C Heinrich; Iris Behrmann; Serge Haan; Heike M Hermanns; Gerhard Müller-Newen; Fred Schaper
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

6.  Characterization of the rat oncostatin M receptor complex which resembles the human, but differs from the murine cytokine receptor.

Authors:  Johannes Drechsler; Joachim Grötzinger; Heike M Hermanns
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

Review 7.  The enigmatic cytokine oncostatin m and roles in disease.

Authors:  Carl D Richards
Journal:  ISRN Inflamm       Date:  2013-12-08

8.  Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.

Authors:  Karen Kwofie; Matthew Scott; Rebecca Rodrigues; Jessica Guerette; Katherine Radford; Parameswaran Nair; Carl D Richards
Journal:  Respir Res       Date:  2015-02-07

Review 9.  Endosomes as Signaling Platforms for IL-6 Family Cytokine Receptors.

Authors:  Dirk Schmidt-Arras; Stefan Rose-John
Journal:  Front Cell Dev Biol       Date:  2021-06-01

10.  Oncostatin M and TLR-4 ligand synergize to induce MCP-1, IL-6, and VEGF in human aortic adventitial fibroblasts and smooth muscle cells.

Authors:  David Schnittker; Karen Kwofie; Ali Ashkar; Bernardo Trigatti; Carl D Richards
Journal:  Mediators Inflamm       Date:  2013-11-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.